[On 2-benzolsulfonylamino-5(beta-methoxy-ethoxy)-pyrimidine (glycodiazine. V. In vitro and in vivo experiments on the action of phenylethylbarbituric acid (Luminal) on the metabolism and blood sugar reducing effect of glycodiazine].
D000328:Adult; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D004285:Dogs; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D010477:Perfusion; D010634:Phenobarbital / Q000494:pharmacology*; D011743:Pyrimidines / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D012159:Reticulum / Q000378:metabolism; D014044:Tolbutamide / Q000378:metabolism*; D014316:Tritium
D001786:Blood Glucose; D011743:Pyrimidines; D014316:Tritium; D014044:Tolbutamide; D010634:Phenobarbital
Uber 2-benzolsulfonylamino-5(beta-methoxy-äthoxy)-pyrimidin (Glycodiazin). V. In vitro-und in vivo-Versuche zum Einfluss von Phenyläthylbarbitursäure (Luminal) auf den Stoffwechsel und die blutzuckersenkende Wirkung des Glycodiazins.